BRCA1 and ovarian cancer: Previous studies have indicated that ovarian cancer subtypes with higher BRCA1 mutations correspond to environments with higher expression levels of immune checkpoint molecules and elevated levels of infiltrating immune cells, consistent with our results (Wei et al., 2020; Zheng et al., 2020).